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ABSTRACT 
Background:  
Little is known about the clinical management of patients in primary care following self-
harm. 
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Methods:  
A descriptive cohort study using data from 684 UK general practices that contributed to the 
Clinical Practice Research Datalink (CPRD) during 2001-2013. We identified 49,970 patients 
with a self-harm episode, 41,500 of whom had one complete year of follow-up.  
Results:  
Among those with complete follow-up, 26,065 (62.8%, 62.3-63.3) were prescribed 
psychotropic medication and 6,318 (15.2%, 14.9-15.6) were referred to mental health 
services; 4,105 (9.9%, CI 9.6-10.2) were medicated without an antecedent psychiatric 
diagnosis or referral, and 4,506 (10.9%, CI 10.6-11.2) had a diagnosis but were not 
subsequently medicated or referred. Patients registered at practices in the most deprived 
localities were 27.1% (CI 21.5-32.2) less likely to be referred than those in the least deprived. 
Despite a specifically flagged NICE ‘Do not do’ recommendation in 2011 against prescribing 
tricyclic antidepressants following self-harm because of their potentially lethal toxicity in 
overdose, 8.8% (CI 7.8-9.8) of individuals were issued a prescription in the subsequent year. 
The percentage prescribed Citalopram, an SSRI antidepressant with higher toxicity in 
overdose, fell sharply during 2012/2013 in the aftermath of a Medicines and Healthcare 
products Regulatory Agency (MHRA) safety alert issued in 2011.  
Conclusions:  
A relatively small percentage of these vulnerable patients are referred to mental health 
services, and reduced likelihood of referral in more deprived localities reflects a marked 
health inequality. National clinical guidelines have not yet been effective in reducing rates of 
tricyclic antidepressant prescribing for this high-risk group.  
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INTRODUCTION 
 
Self-harm is one of the strongest risk factors for death by suicide (Cooper et al., 2007; Bergen 
et al., 2012) and general practitioners (GPs) play an important role in managing risk among 
patients who have recently harmed themselves. However, research evidence for the clinical 
management of self-harm specifically in primary care settings is lacking because most 
published studies have been conducted using hospital emergency department and admissions 
data. Nonetheless, the important role played by primary care in the assessment of people who 
self-harm was emphasised in 2004 by National Institute for Health and Care Excellence 
(NICE) clinical guideline 16: Self-harm: the short-term physical and psychological 
management and secondary prevention of self-harm in primary and secondary care.
 
(NICE, 
2004) Despite this strong emphasis, just 14 of its 152 recommendations provided instruction 
to primary care teams, and this was the case for only 3 of the 57 recommendations made in 
2011 by NICE clinical guideline 133: Self-harm: longer-term management. (NICE, 2011) 
This lack of recommendations specific to primary care is linked to the absence of research 
evidence for this topic.  
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We examined a cohort extracted from the Clinical Practice Research Datalink (CPRD).(DoH, 
2011; Herrett et al., 2015) This data source enabled us to examine primary care clinical 
management following an episode of self-harm using data from general practices located 
across the UK. The purpose was not to comprehensively ascertain all incident cases of self-
harm in the population, including all cases treated in secondary care settings. Rather it was to 
investigate individuals whose recent self-harm episodes have been brought to the attention of 
their GPs. We initially profiled those patients who had an antecedent psychiatric diagnosis or 
a new one following their index self-harm episode. However, our primary outcomes were the 
percentage of cohort members receiving a referral to mental health services or prescribed 
psychotropic medication in the subsequent year. We paid particular attention to medication 
that can be fatally toxic in overdose, such as tricyclic antidepressants. Finally, we aimed to 
assess variability in clinical management by age and gender and by practice-level 
deprivation.  
 
 
METHODS 
 
Description of the data source and study cohort 
 
The December 2013 CPRD extract that we examined included 684 general practices and 
more than 13 million patients, with age and gender distributions comparable to those for the 
whole UK population.(Herrett et al., 2015; Garcia Rodriguez, 1998) Validation studies have 
reported consistently high CPRD quality data.(Herrett et al., 2015; Khan et al., 2010) The 
Read code system,(Chisholm, 1990) the standard for UK general practice, is routinely applied 
5 
 
in the dataset. It provides a structured hierarchy of terms relating to demography and lifestyle, 
symptoms, diagnoses, therapies, referrals, and laboratory test results.(HSCIC, 2015)  
 
We delineated the study cohort using a broad definition that incorporated all forms of self-
harm from the mildest non-suicidal episodes through to near-fatal attempted suicide, as 
described previously.(Carr et al., 2015) Our definition excluded alcohol-related poisonings 
and suicidal ideation not involving actual self-harm acts. We initially identified potentially 
relevant Read codes using the search terms 'deliberate', 'intent' or 'self' (to identify episodes of 
self-harm/harming, self-injury/injurious behaviour, self-inflicted harm/injury, harm/injury to 
self, self-poisoning, deliberate overdose, intentional overdose, etc.) and 'suicide attempt', 
'attempted suicide' or 'parasuicide' (to identify suicide attempts). The list of codes was then 
reviewed rigorously by two clinicians in the study team (NK and JC) and cross-referenced 
with a comparable list obtained from a recent CPRD-based validation study on suicide and 
self-harm.(Thomas et al., 2013) Our final list can be downloaded from the 
‘ClinicalCodes.org’ repository.(Springate et al., 2014) 
 
An index self-harm episode was defined as the first occasion on which a Read code from our 
list was entered in a patient’s clinical record. Limiting our extraction to patients deemed as 
being ‘up to standard’ for research purposes by the CPRD, our cohort consisted of individuals 
with a recorded index episode from 1
st
 January 2001 to 31
st
 December 2012. Patients were 
eligible for inclusion in a given year if they were aged 15-64 years and registered with a 
CPRD-contributing practice at the start of the year. The rationale for imposing these age 
restrictions was that the determinants and implications of self-harm in children and older 
adults are quite distinct from those of the rest of the population, and therefore warrant 
separate investigation and consideration. Among older persons who harm themselves, 
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specific mechanisms such as bereavement, loneliness and social isolation (De leo et al., 2001; 
Lebret et al., 2006) and physical illness, multi-morbidity and impairment (Lebret et al., 2006) 
play a predominant role; children aged below 15 years who harm themselves tend to have an 
unusually low suicidal intent and therefore a relatively low long-term risk of dying by 
suicide.(Hawton et al., 2008) To increase the likelihood that these were incident cases on 
entry into the study cohort, we stipulated that patients had to have been registered with a 
contributing CPRD practice on a continuous basis for at least a year prior to the index self-
harm episode. 
 
Classification and measurement 
 
Referrals and prescriptions:  
These were our two primary clinical management measures. We examined referrals to mental 
health services and psychotropic medication prescribing that was recorded subsequent to the 
index self-harm episode and during the 1 year follow-up period. We identified referrals to 
relevant mental health services using two CPRD fields. Firstly, a Family Health Services 
Authority (FHSA) variable indicated the department to which the patient was referred. 
General practitioners are required to enter this information upon referral, and for our purposes 
‘Psychiatry’ was the only relevant department. Secondly, we also utilised the National Health 
Service (NHS) specialty field. This contains more granular information, but completion by 
general practice staff is not compulsory when coding referrals. The NHS specialty 
classification included eight mental health codes: mental illness; child and adolescent 
psychiatry; forensic psychiatry; psychotherapy; old age psychiatry; clinical psychology; adult 
psychiatry; and community psychiatric nurse. We combined information from both the FHSA 
and NHS fields to construct a binary specialist mental health services referral indicator. The 
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dataset also contains complete records of all prescribed medication. We extracted all 
prescriptions in the following psychotropic medication classes: typical, atypical and depot  
antipsychotics; lithium and other mood stabilisers; selective serotonin reuptake inhibitor 
(SSRI), tricyclic and other antidepressants; benzodiazepines; opioid analgesics; other 
anxiolytics and hypnotics. Our list of Multilex product (FirstDataBank, 2014) codes for 
denoting psychotropic medications can be downloaded from ‘ClinicalCodes.org’.(Springate 
et al., 2014) 
 
Diagnoses:  
Psychiatric diagnoses were measured according to any prior history or a new diagnosis made 
after the index self-harm episode. They were classified as: schizophrenia-spectrum; bipolar 
disorder; depression; anxiety disorders; personality disorders; and eating disorders. Read 
code lists were compiled for each diagnostic category and were reviewed by two clinically 
qualified study team members (NK and JC). The final lists can be accessed at 
‘ClinicalCodes.org’ (Springate et al., 2014); a rationale for these coding decisions is given in 
supplemental file 1.  
 
Clinical consultation:  
The CPRD 'consultation type' field contains 59 categories, including numerous options that 
denote telephone consultations or administrative processes. A previous CPRD-based case-
control study of death by suicide found that just eight of these categories were used in 96% of 
patient record entries.(Appleby et al., 2014) As in that study, to provide a stringent measure 
of face-to-face contact with a GP or practice nurse, we applied categories 1 (‘clinic’) and 9 
(‘surgery consultation’) only to derive our clinical consultation count variable.  
 
Deprivation:  
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We applied an ecological measure at practice postcode level: the 2010 Indices of Multiple 
Deprivation (IMD) for England, Wales, Scotland and Northern Ireland.(Department for 
Communities and Local Government (England), 2012; The Scottish Government, 2010; The 
Welsh Government, 2010; Northern Ireland Statistics & Research Agency, 2010) The IMD 
reflects social and material deprivation among areas generally housing 1000-3000 residents, 
enabling rank ordering of area-level scores. We examined four separate quintile variables, 
which were generated from the continuous IMD scores, according to the distributions of the 
four UK nations. 
 
Statistical analyses 
 
All analyses were performed using Stata version 13.(StataCorp, 2013) We examined clinical 
events occurring within one year after the index self-harm episode. We stratified our analyses 
by gender, age in 10-year intervals and deprivation quintile. Due to the large cohort size and 
abundant statistical power, we found numerous instances of statistically significant 
heterogeneity by gender, age and deprivation albeit with only small absolute differences 
observed. Thus, we placed greater emphasis on the strength of association rather than p-
values. We calculated 95% confidence intervals for binomial proportions using Wilson’s 
method (Wilson, 1927) rather than applying a normal approximation, and we used 
Koopman’s method to calculate the confidence interval for a ratio of two proportions. 
(Koopman, 1984) The final cohort observation date was 31
st
 December 2013. Therefore, 
patients with index episodes after 31
st
 December 2012 were excluded because a full year of 
follow-up data was unavailable. We calculated the time elapsed from index self-harm episode 
to first recorded subsequent referral, only for those referrals occurring within a year of the 
index episode.  
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RESULTS 
 
Description of the study cohort 
 
The full cohort consisted of 47,970 patients with an index self-harm episode during 2001-
2012. The median follow-up time was 3.7 years (interquartile range: 1.7-6.8 years) and 
41,500 (86.5%) patients had at least one full year of follow-up. Thus, 6470 patients (13.5%) 
did not complete the full follow-up year, with the percentage being higher in male patients 
than in females (15.5% vs. 12.0%: Table 1). Almost a tenth (4,475; 9.3%, CI 9.1-9.6) of the 
total cohort with an index self-harm episode transferred to another practice during the follow-
up year, and 1,052 (2.2%, 2.1-2.3) died; 4.0% (CI 3.7-4.2) of the male patients and 0.9% (CI 
0.8-1.0) of the females died. Most of the 41,500 patients in the cohort with complete follow-
up were female (24,317; 58.6%). They tended to be somewhat younger than their male 
counterparts, with a median age of 29 versus 31 years for males. 
 
 
 
 
Psychiatric diagnoses, and subsequent referral and medication prescribing 
 
For the remainder of the Results section, we focus on the cohort members with a full year of 
follow up. Almost two thirds (26,389; 63.6%, CI 63.1-64.1) had an antecedent or new 
psychiatric diagnosis. Table 2 presents the percentages of patients who received psychotropic 
medication prescriptions or were referred to mental health services referrals in the year after 
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their index episode: 6,318 (15.2%, CI 14.9-15.6) were referred and 26,065 (62.8%, 62.3-63.3) 
were prescribed psychotropic medication. No strong gender differences in these percentages 
were apparent, but older patients of both genders were far more likely to receive a 
prescription after the index episode. Of the 6,318 referrals recorded, the majority (3,368; 
53.3%) occurred within the first month of follow-up. Patients registered with practices in the 
most deprived localities were 27.1% (CI 21.5-32.2) less likely to be referred than those in the 
least deprived. Figure 1 highlights the downward gradient in rates of referral to mental health 
services in relation to rising levels of deprivation, whilst the number of referrals increased 
incrementally from the least to the most deprived IMD quintile. 
 
The Venn diagram shown in Figure 2 depicts the percentages of cohort members who had 
antecedent or new psychiatric diagnoses, and who were referred or medicated during the 
follow-up year.  4,105 (9.9%, CI 9.6-10.2) were prescribed psychotropic medication without 
a diagnosis or subsequent referral to mental health services, and 4,506 (10.9%, CI 10.6-11.2) 
had a diagnosis but were not subsequently medicated or referred. Almost a quarter of cohort 
members (9,648; 23.2%, CI 22.8-23.7) had no psychiatric diagnosis and were not 
subsequently referred or medicated. 
 
In supplemental file 2, we provide detailed information on diagnostic categories recorded at 
any time (historically or in the follow-up year combined), and new diagnoses made 
specifically during the 1 year follow-up. Consistent with prior expectation, the numerically 
dominant diagnostic groups in both genders were depression followed by anxiety disorders. 
Gender differences were modest for all diagnostic categories examined. In Table 3 we present 
the percentages of patients receiving prescriptions for individual psychotropic medication 
classes during the follow-up year. Predictably, SSRI antidepressants were the most frequently 
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prescribed drug type, and other antidepressants, benzodiazepines, opioid analgesics and other 
anxiolytics/hypnotics were also commonly prescribed. 
Although they are known to be potentially fatally toxic in overdose, almost a tenth (3,985; 
9.6%, CI 9.3-9.9) of cohort members were prescribed tricyclic antidepressant medication 
during the year after their index self-harm episode. Because of the clinical importance of this 
finding, we additionally examined temporal trends in SSRI versus tricyclic antidepressant 
prescribing. The trends plotted in Figure 3a show increases in the percentages of cohort 
members prescribed SSRIs and other non-tricyclic antidepressant types during the follow-up 
year across the whole study period, but there was no compensatory fall over time in the 
percentage of patients prescribed a tricyclic. This percentage remained high throughout the 
12 years of observation; it was 8.8% (CI 7.8-9.8) among patients whose index self-harm 
episode occurred during 2012 and who were followed up into 2013.  
Figure 3b plots temporal trends in the percentages of patients prescribed specific types of 
SSRIs. There was no discernible trend over the observation period in the percentages 
prescribed Fluoxetine or Fluvoxamine maleate. The percentage prescribed Paroxetine fell 
over time, especially in the earlier years of observation, and that for Sertraline increased 
sharply during the later years. Finally, the percentages prescribed Citalopram, and its S-
enantiomer Escitalopram, fell over time; for Citalopram the percentage rose steadily across 
the study period until falling sharply in 2012/2013 with cohort members whose index self-
harm episodes occurred during 2012.        
We examined the characteristics of the patients in the study cohort were who were prescribed 
tricyclic antidepressant medication. Of the 3985 patients prescribed a tricyclic antidepressant 
within a year of their index self-harm episode, 2466 (61.9%) were female and 64.8% were 
aged 35 years or older. Most patients (70.4%) had a diagnosis of depression prior to the date 
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of their first tricyclic prescription during follow-up, and 10.4% had a diagnosis of depression 
recorded on the same day as this prescription was issued. 
In Table A3 (in the online supplemental material), we present the frequencies and percentage 
values for the following three measures: 
1. Ever prescribed an SSRI and/or other ADD at any time before first tricyclic 
prescription during follow-up 
2. Prescribed an SSRI and/or other ADD within a year prior to first tricyclic prescription 
during follow-up 
3. Prescribed an SSRI and/or other ADD between index self-harm episode and first 
tricyclic prescription during follow-up 
The purpose of these analyses was to assess the degree to which tricyclic antidepressant 
medication was used as first-line treatment in the study cohort, as opposed to being a 
therapeutic approach that was taken only after SSRIs and/or other antidepressants had been 
prescribed. Among those prescribed tricyclics, 22.3% (95% CI 21.0-23.6%) had never been 
prescribed an SSRI and/or any other type of antidepressant, 39.2% (CI 37.7-40.7%) had not 
been prescribed these alternative antidepressant therapies within a year of first being 
prescribed tricyclics, and 64.5% (63.0-65.9%) had not been prescribed them between index 
self-harm episode and subsequent first tricyclic prescription. Among the subset of cohort 
members prescribed tricyclics, prior prescribing of an SSRI and/or another type of 
antidepressant medication was more common in female than in male patients.  
 
Consultation patterns 
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The median consultation frequency during the year after the index episode was 7 visits 
(interquartile range: 3-12). Male patients consulted less frequently, with a median of 5 visits 
(interquartile range: 2-10), compared with a median among females of 8 visits (interquartile 
range: 4-13). Overall, 2,961 (7.1%, CI 6.9-7.4) cohort members did not consult once during 
the follow-up year, with males being more likely to be non-attenders (1,954; 11.4%, CI 10.9-
11.9) than females (1,007; 4.1%, CI 3.9-4.4).   
 
 
DISCUSSION 
 
Key findings 
 
For the first time, this study provides population-based evidence illustrating clinical 
management patterns among UK patients in primary care who have recently harmed 
themselves. Our findings indicate that general practices have major challenges to address if 
they are to provide optimal care for patients following self-harm. The most important 
findings were as follows: 
1) Overall, the percentage of patients subsequently referred to mental health services was 
relatively low, and patients registered at practices in more deprived areas were less likely to 
be referred than those in less deprived areas. 
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2) Almost a tenth of cohort members were prescribed psychotropic medication without an 
antecedent or new psychiatric diagnosis or subsequent referral to mental health services, and 
nearly eleven percent had a diagnosis but were not subsequently medicated or referred. 
3) A considerable proportion of patients, almost a tenth across the whole 12-year observation 
period and still nearly nine percent during 2012-2013, received potentially fatally toxic 
tricyclic antidepressant medication soon after harming themselves, and twenty-two percent of 
these patients had never been prescribed a different type of antidepressant drug previously. 
4) The percentage of cohort members prescribed Citalopram fell sharply during 2012/2013.  
5) Nearly a tenth of cohort members moved practices during the follow-up year and, among 
those patients with a complete year of follow-up, 7 percent did not consult with a GP or 
practice nurse in that period. 
 
Comparison with existing evidence 
 
With around 220,000 presentations of self-harm occurring annually,(Hawton et al,. 2007) 
much of the research evidence for self-harm in the UK and other developed countries has 
been generated through studies conducted using hospital emergency department and 
admissions data. Some evidence, does, however, exist for patterns of consultation in primary 
care following self-harm. One study found that most people consult with their GP soon after 
an episode, providing an opportunity to intervene and prevent further episodes.(Gunnell et al., 
2002) We found the overall rate of psychiatric referral to specialist mental health services in 
the year following self-harm to be around just 15% for all patients combined, which is lower 
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than the 25% cited in relation to hospital-based presentations.(Kapur et al., 2006) Given the 
complex health needs of this patient group, a higher referral rate by GPs might be expected. 
Because of the lack of relevant research we do not know what the optimal referral rate ought 
to be in this population and setting, but the apparently low rate is certainly a concern that 
merits further investigation. We have previously reported from the CPRD that patients 
registered at practices in more deprived localities have a higher incidence and annual 
presentation of self-harm.(Carr et al., 2015) Thus, the decreasing referral rate with heightened 
levels of socioeconomic deprivation that we report here provides a clear illustration of Tudor 
Hart’s 'Inverse Care Law',(Tudor Hart, 1971) whereby the provision of services is inversely 
associated with the level of needs in the population.(Chew-Graham et al., 2002; Mercer and 
Watt, 2007) 
 
Many previous studies have documented the severe and complex needs of people who have 
harmed themselves. This body of evidence indicates why these individuals require optimal 
clinical management in primary care. People who have self-harmed have a very high 
prevalence of mental illness, particularly depression and anxiety disorders in adults and 
attention deficit hyperactivity disorder (ADHD) and conduct disorder in adolescents.(Hawton 
et al., 2013) They commonly have comorbid substance misuse and psychological 
distress,(Moller et al., 2013) and they are also more likely to perpetrate violence and be 
victims of it.(Vaughn et al., 2015) They are particularly prone to dying prematurely, 
specifically by suicide or accidental poisoning (Cooper et al., 2007; Bergen et al., 2012; 
Finkelstein et al., 2015a, 2015b) and from alcohol-related causes.(Bergen et al., 2014) In a 
cohort study conducted in three English cities, mean potential Years of Life Lost (YLL) for 
all-cause mortality were 31·4 years in males and 30·7 years in females.(Bergen et al., 2012) 
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As well as the apparent under-treatment of these patients, the prescribing of psychotropic 
medication without a psychiatric diagnosis is also potentially problematic, because it 
represents a departure from evidence-based clinical practice.  
 
Careful prescribing is required for vulnerable primary care patients at elevated risk of self-
poisoning (Hawton and Blackstock, 1976, 1977) and in particular those individuals who have 
already harmed themselves. Monitoring patients in the early stages of treatment is therefore 
essential, as is balancing the risks of suicide and self-harm versus the efficacy of medications 
in treating the underlying mental illness.(Gunnell et al., 2005) Many previous studies have 
reported on the potentially harmful effects of specific psychotropic medication classes. A 
comprehensive systematic review on the topic highlighted tricyclic antidepressants and 
certain types of selective serotonin reuptake inhibitor (SSRI) antidepressants as having 
heightened fatal toxicity risk in overdose.(Flanagan, 2008) Other research has confirmed the 
toxicity of tricyclics (Hawton et al., 2010) and have identified potential risks in overdose 
associated with certain SSRIs,(Gunnell et al., 2005) most notably Citalopram.(Hawton et al., 
2010; Barbui and Patten, 2014)
 
 
One investigation reported aggregated Primary Care Trust (PCT)-level antidepressant 
prescribing data in years 2004-2006 for three English cities, and patient-level data for 
emergency department self-poisoning cases at hospitals in these cities during 2000-
2006.(Bergen et al., 2010) The authors described marked inter-PCT variability in 
antidepressant prescribing patterns and self-poisoning profiles with these drugs, and 
highlighted a specific concern regarding the continued prescribing of toxic tricyclics in this 
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population. NICE clinical guideline 133 (CG133, recommendation 1.5.2; page 25) states: 
“When prescribing drugs for associated mental health conditions to people who self-harm, 
take into account the toxicity of the prescribed drugs in overdose. For example, when 
considering antidepressants, selective serotonin reuptake inhibitors (SSRIs) may be preferred 
because they are less toxic than other classes of antidepressants. In particular, do not use 
tricyclic antidepressants, such as dosulepin, because they are more toxic.” On the NICE 
CG133 website, recommendation 1.5.2 is flagged separately as being one of only three ‘Do 
not do’ recommendations from that guideline 
(https://www.nice.org.uk/guidance/cg133/resources/do-not-do). Although it was published in 
November 2011, we found no evidence of a marked decline in tricyclic prescribing for cohort 
members whose index self-harm episodes occurred during 2012 and were followed up into 
2013. Of course this is a relatively short post-intervention time period, and it is feasible that 
prescription levels may have fallen subsequently. Nonetheless, we did observe a sharp fall 
during 2012/2013 in the percentage of patients who were prescribed Citalopram. This 
followed a Medicines and Healthcare products Regulatory Agency (MHRA) safety alert 
issued in December 2011 that focussed on cardiovascular risks (https://www.gov.uk/drug-
safety-update/citalopram-and-escitalopram-qt-interval-prolongation). 
 
Almost four fifths of patients who were prescribed a tricyclic antidepressant during follow-up 
after their index self-harm episode had been prescribed an SSRI or some other antidepressant 
drug agent previously. This indicates that tricyclics are generally not being selected as first-
line treatment. Second-line use may seem a more clinically justifiable option as the self-harm 
event itself might suggest that the patient is not responding adequately well to earlier 
treatment with alternative antidepressant medications. That other antidepressant drugs have 
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usually been tried previously adds useful insight into the challenges of clinical consultation in 
primary care, although twenty two percent of these patients appear to have been prescribed 
tricyclics in preference to alternative antidepressant agents.     
 
Strengths and limitations 
 
Approximately 6.9% of the UK population is registered at practices reporting data to the 
CPRD, which is broadly representative of the whole population nationally in terms of age, 
gender and ethnicity.(Herrett et al., 2015) From this resource we extracted a large cohort to 
investigate a relatively rare phenomenon with abundant statistical power to examine 
subsequent primary care management profiles. Observational studies conducted in the CPRD 
rely on the standard of data inputted by GPs and other practice staff members. Data quality is, 
however, carefully monitored, and we restricted our analysis to those practices that were 
deemed to be up-to-standard for research purposes as defined by CPRD. The dataset 
conferred a number of specific advantages, including: (i) Diagnostic coding of a high 
standard (Khan et al., 2010); (ii) Mandatory recording of referrals to mental health services; 
and (iii) Recording of all medication prescribed in primary care. Our study did have some 
specific limitations. Firstly, we had no information on the uptake of referrals, and we could 
not determine whether a patient was already under the care of psychiatric services or, indeed, 
the date of commencement of such care. Secondly, psychological therapies and other non-
medicinal treatments were not systematically recorded in the dataset. Finally, we assigned 
deprivation scores at practice level as proxies for patient-level measures. 
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CONCLUSIONS 
 
Rates of referral to mental health services are relatively low among these patients, and a stark 
health inequality is evident in relation to a lower likelihood of being referred among patients 
registered at practices located in more deprived areas. A greater level of adherence to the 
2011 NICE CG133 ‘Do not do’ recommendation against tricyclic antidepressant prescribing 
is also indicated. However, our findings also indicate that sizeable proportions of primary 
care patients move to another practice, or fail to consult with a GP or nurse, within a year of 
harming themselves. This represents a major challenge for general practices in monitoring 
these patients and in providing high quality care. Guidelines for GPs on managing patients 
with history of self-harm are currently limited, and further research is needed to determine 
how risks might be lowered through improved primary care clinical intervention.  
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Table 1: Cohort members’ demographic information 
    
 All Male Female 
Total cohort size (N) 
47,970 20,325 27,645 
Gender (%) 
- 42.4 57.6 
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Median age (IQR) 
30 (20,42) 32 (22,43) 28 (19,41) 
Patients with less than 1 year of follow-up: 
   
Number of patients (% of Total N) 
6,470 (13.5) 3,142 (15.5) 3,328 (12.0) 
Gender (row %) 
- 48.6 51.4 
Median age (IQR) 
31 (21,42) 34 (24,45) 27 (19,39) 
Lost to follow-up (% of Total N): 
   
 Died from any cause 
2.1 3.8 0.9 
 Transferred out of practice 
9.3 9.7 9.0 
 Practice no longer contributing to CPRD  
2.1 1.9 2.2 
Patients with complete 1 year of follow-up: 
   
Number of patients (% of Total N) 
41,500 (86.5) 17,183 (84.5) 24,317 (88.0) 
Gender (row %) 
- 41.4 58.6 
Median age (IQR) 
30 (20,42) 31 (22,43) 29 (19,42) 
Table 2: Mental health services referrals and psychotropic  
medication prescriptions during 1 year follow-up 
  Total Referred Prescribed 
  N n % n % 
       
Overall  41,500 6,318 15.2 26,065 62.8 
       
Male  17,183 2,467 14.4 10,405 60.6 
 Age       
  15-24  5,925 813 13.7 2,397 40.5 
  25-34  3,898 586 15.0 2,485 63.8 
  35-44  3,702 557 15.1 2,698 72.9 
  45-54  2,374 337 14.2 1,818 76.6 
  55-64  1,284 174 13.6 1,007 78.4 
 IMD quintile       
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  1  2,182 383 17.6 1,318 60.4 
  2  2,743 439 16.0 1,647 60.0 
  3  3,185 488 15.3 1,969 61.8 
  4  4,146 548 13.2 2,530 61.0 
  5  4,927 609 12.4 2,941 59.7 
       
Female  24,317 3,851 15.8 15,660 64.4 
 Age       
  15-24  10,368 1,557 15.0 4,364 42.1 
  25-34  4,348 780 17.9 3,293 75.7 
  35-44  4,957 841 17.0 4,069 82.1 
  45-54  3,255 497 15.3 2,754 84.6 
  55-64  1,389 176 12.7 1,180 85.0 
 IMD quintile       
  1  3,444 632 18.4 2,207 64.1 
  2  4,255 776 18.2 2,771 65.1 
  3  4,610 752 16.3 2,939 63.8 
  4  5,718 824 14.4 3,698 64.7 
  5  6,290 867 13.8 4,045 64.3 
       
 Patients that did not complete one year of follow-up were excluded 
IMD quintile 1 denotes least deprived and quintile 5 most deprived  
Table 3: Psychotropic prescribing by type during 1 year follow-up 
 
All 
(N = 41,500) 
Male 
(N = 17,183) 
Female 
(N = 24,317) 
Psychotropic medication n % n % n % 
 
Typical antipsychotics 2,292 5.5 773 4.5 1,519 6.3 
Atypical antipsychotics 3,319 8.0 1,556 9.1 1,763 7.3 
Depot antipsychotics 72 0.2 31 0.2 41 0.2 
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Lithium and other mood stabilisers 1,901 4.6 787 4.6 1,114 4.6 
SSRI antidepressants 17,030 41.0 6,280 36.6 10,750 44.2 
Tricyclic antidepressants 3,985 9.6 1,519 8.8 2,466 10.1 
Other antidepressants 6,580 15.9 2,586 15.1 3,994 16.4 
Benzodiazepines 7,637 18.4 3,139 18.3 4,498 18.5 
Opioid analgesics 5,605 13.5 2,252 13.1 3,353 13.8 
Other anxiolytics and hypnotics 5,592 13.5 2,201 12.8 3,391 13.9 
Any psychotropic medication  26,065 62.8 10,405 60.6 15,660 64.4 
 
All analyses restricted to patients with at least one year of follow-up 
Figure 1. Percentage of patients referred to mental health services during the 1 year 
follow-up compared with number who self-harmed by deprivation quintile. 
Figure 2. Venn diagram showing percentage values for patients with antecedent or 
new psychiatric diagnoses and with mental health service referrals or psychotropic 
drug prescriptions during the 1 year follow-up. 
Figure 3a. Temporal trends in the percentage of cohort members prescribed 
tricyclics, SSRIs and other antidepressants during the 1 year follow-up. Figure 3b. 
Temporal trends in the percentage of cohort members prescribed particular types of 
SSRI antidepressants during the 1 year follow-up. 
Footnote: The x-axis values show the calendar year period when index self-harm episodes occurred. Each cohort 
member was followed up for 1 complete year. Thus, an individual born on 31
st
 December 2012 was followed up 
to 31
st
 December 2013, which was the final date of observation in our study  
Highlights 
 The percentage of patients referred to mental health services is low 
 Patients in the most deprived localities have the least chance of being referred 
 One in ten are prescribed medication without a diagnosis or referral  
 Eleven percent have a diagnosis but are not medicated or referred 
 Despite guidance, a sizeable proportion were prescribed potentially toxic medication 
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